Ocera Therapeutics, Inc. – Plans of Reorganization, Merger, Acquisition or Similar – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 112 pages Agreement and Plan of Merger by and Among Mak LLC, Meh Acquisition Co., Ocera Therapeutics, Inc. And, Solely for Purposes of Section 8.16, Mallinckrodt PLC Dated as of November 1, 2017

from 8-K/A 45 pages Technology Transfer and License Agreement by and Between Genentech, Inc., F. Hoffmann-La Roche Ltd and Ocera Therapeutics, Inc

from 8-K/A 45 pages Technology Transfer and License Agreement by and Between Genentech, Inc., F. Hoffmann-La Roche Ltd and Ocera Therapeutics, Inc

from 8-K 41 pages Technology Transfer and License Agreement by and Between Genentech, Inc., F. Hoffmann-La Roche Ltd and Ocera Therapeutics, Inc

from DEFA14A 86 pages Agreement and Plan of Merger and Reorganization Among: Tranzyme, Inc., a Delaware Corporation; Terrapin Acquisition, Inc., a Delaware Corporation; and Ocera Therapeutics, Inc., a Delaware Corporation Dated as of April 23, 2013

from 8-K 86 pages Agreement and Plan of Merger and Reorganization Among: Tranzyme, Inc., a Delaware Corporation; Terrapin Acquisition, Inc., a Delaware Corporation; and Ocera Therapeutics, Inc., a Delaware Corporation Dated as of April 23, 2013